Skip to main content

Month: June 2020

DIGITAL ALLY PRICES $5.1 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK

Lenexa, KS, June 02, 2020 (GLOBE NEWSWIRE) — Digital Ally, Inc. (DGLY) (the “Company”), which develops, manufactures and markets advanced video recording products for law enforcement, emergency management, fleet safety and security, today announced the pricing of an underwritten public offering of 3,090,909 shares of its common stock at a price of $1.65 per share, for gross proceeds to the Company of approximately $5.1 million, before deducting underwriting discounts and other offering expenses. The Company intends to use the net proceeds from this offering for working capital, product development, order fulfillment and for general corporate purposes.In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 463,636 shares of common stock offered in the public offering to cover over-allotments,...

Continue reading

Eik fasteignafélag hf.: Breytingar á viðskiptavakt

Arion banki, viðskiptavaki félagsins, hefur tilkynnt félaginu að bankinn telji ekki lengur fyrir hendi þörf á að beita heimild í samningi um viðskiptavakt til frestunar á skyldum vegna óviðráðanlegra atvika og því gildi að nýju ákvæði samningsins um verðbil og fjárhæðir.Félagið tilkynnti 12. mars 2020 um að Arion banki teldi sér heimilt að víkja frá skilyrðum í viðskiptavakasamningi vegna óviðráðanlegra atvika. Nánari upplýsingar veitir:Lýður H. Gunnarsson, framkvæmdastjóri fjármálasviðs, lydur@eik.is, s. 820-8980

Continue reading

REITIR: Afturköllun breytinga á skilmálum viðskiptavaka

Reitum hefur borist tilkynning frá Arion banka sem sinnir viðskiptavakt með hlutabréf félagsins, um að ekki sé lengur nauðsynlegt að beita heimild í samningi aðila til að víkja frá skilyrðum hans hvað varðar verðbil og fjárhæðir í óviðráðanlegum aðstæðum, sjá fyrri tilkynningu þar um hér.Gilda því ákvæði samnings Reita og Arion banka um verðbil og fjárhæðir nú að nýju.Nánari upplýsingar veitir Einar Þorsteinsson, fjármálastjóri, í síma 669-4416.

Continue reading

Aduro Biotech Presents Nonclinical and Phase 1 Healthy Volunteer Data for BION-1301 at the 57th ERA-EDTA Virtual Congress

BION-1301 was well-tolerated, with no serious adverse events (SAEs), treatment discontinuations or events meeting stopping criteria, across a wide range of dosesPharmacokinetics (PK) of BION-1301 were generally dose-proportional with an estimated half-life of 33 days, suggesting the potential for monthly dosing BION-1301 dose-dependently and durably reduced IgA and IgM, and to a lesser extent, IgG, providing a pharmacodynamic (PD) window to potentially exploit reductions in IgA while tempering reductions in IgG No tox findings were reported in nonclinical toxicology studies of BION-1301 evaluating intravenous (IV) administration for up to 6 months and subcutaneous (SC) administration for up to 1 monthBERKELEY, Calif., June 02, 2020 (GLOBE NEWSWIRE) — Aduro Biotech, Inc. (NASDAQ: ADRO), a clinical-stage biopharmaceutical company...

Continue reading

WillScot Announces Upsizing And Pricing of $650 Million Senior Secured Notes Offering

BALTIMORE, Md., June 02, 2020 (GLOBE NEWSWIRE) — WillScot Corporation (Nasdaq: WSC) (“WillScot”), a specialty rental services market leader providing innovative modular space and portable storage solutions across North America, today announced that its indirect subsidiary Picasso Finance Sub, Inc. (the “Issuer”) has priced its offering of $650 million in aggregate principal amount of 6.125% senior secured notes due 2025 (the “Notes”). WillScot upsized the offering size opportunistically from $500 million to $650 million. WillScot intends to use the offering proceeds, together with funds drawn under WillScot’s fully committed $2.4 billion ABL credit facility, to be entered into at the closing of the Merger (as defined below), to repay all outstanding indebtedness under its existing ABL Facility and Mobile Mini, Inc.’s (“Mobile...

Continue reading

SouthGobi announces an update on enforcement of Arbitration Award with First Concept

VANCOUVER, British Columbia, June 02, 2020 (GLOBE NEWSWIRE) — SouthGobi Resources Ltd. (TSX: SGQ, HK: 1878) (“SouthGobi” or the “Company”) announces receipt of a letter dated June 1, 2020 (the “Demand Letter”) from legal counsel to First Concept Industrial Group Limited (“First Concept”) demanding repayment of the outstanding sums and interests pursuant to an enforcement order issued in January 2020 in relation to the arbitration award (the “Arbitration Award”) related to a coal supply agreement with First Concept. The Demand Letter stated that if the Company fails to repay the outstanding payments on or before June 10, 2020, First Concept will initiate a bankruptcy case in the relevant court of Mongolia against SouthGobi Sands LLC, the Company’s subsidiary in Mongolia. For more information regarding the Arbitration Award, the status...

Continue reading

Veritas Farms, Inc. (OTCQB:VFRM) Reports Financial Results for Year Ended December 31, 2019; Continued Record Revenue Growth with 250% Increase in 2019 Revenues over 2018 and 97% Increase in Q4 2019 Revenues over Q4 2018

Fort Lauderdale, FL, June 02, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Veritas Farms, Inc. (OTCQB:VFRM) (“Veritas Farms” or the “Company”), a vertically integrated agribusiness focused on the production of full spectrum hemp oil products with naturally occurring cannabinoids, announced that the Company has reported its operating results for the year ended December 31, 2019, through the filing of its Annual Report on Form 10-K with the SEC. In filing the report, the Company relied on the extended due date allowed by an SEC exemptive order recently implemented as a result of the delays experienced by public companies in completing and filing reports as a result of the COVID-19 outbreak. The report may be viewed at www.sec.gov.Selected Financial Highlights – 2019 compared to 2018 and 4th Quarter 2019 compared to 4th Quarter...

Continue reading

Serengeti Announces 2020 Exploration Permits, Plans and Strategy

VANCOUVER, British Columbia, June 02, 2020 (GLOBE NEWSWIRE) — Serengeti Resources Inc. (SIR: TSX-V) (“Serengeti” or “the Company”) is pleased to report that permits have been received from the Ministry of Energy and Mines (“MEM”) for all activities planned for 2020. The fully funded 2020 field season work is planned to begin in mid-June. It will focus on key opportunities to add value to the advanced Kwanika copper-gold project and to the highest priority regional exploration targets, East Niv and Top Cat. The Company’s programs will be conducted while following health and safety guidelines of the Province of BC issued May 13th, 2020.Serengeti’s and its majority owned subsidiary Kwanika Copper Corporation’s (“KCC”) combined cash position is approximately $2.4 million. These funds are sufficient to fund expenditures...

Continue reading

Matrix Service Company to Present at the Stifel 2020 Virtual Cross Sector Insight Conference

TULSA, Okla., June 02, 2020 (GLOBE NEWSWIRE) — Matrix Service Company (Nasdaq: MTRX) (“Matrix” or “the Company”), a leading contractor to the energy and power markets across North America, announced today that President and Chief Executive Officer John R. Hewitt and Vice President and Chief Financial Officer Kevin Cavanah will be participating in the Stifel 2020 Virtual Cross Sector Insight Conference on Wednesday, June 10, 2020.The Company is currently scheduled to present at the Virtual Conference at 3:20 p.m. eastern time on June 10, 2020. One-on-one virtual meetings with management are also available during the conference with prior notice and may be scheduled by contacting Stifel directly, or by contacting Matrix Service Company at ir@matrixservicecompany.com or Kellie Smythe, Senior Director of Investor Relations at ksmythe@matrixservicecompany.com.About...

Continue reading

Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement

– Combined Company Will Operate as Chinook Therapeutics and Advance Pipeline of Clinical-Stage Programs in Kidney Diseases, Led by Atrasentan and BION-1301 in IgA Nephropathy– Combined Company Will be Well-Funded With Cash Position of ~$200 Million Expected at Closing, Including $25 Million in Additional Investment Committed by Chinook’s Existing Investors– Multiple Clinical and Regulatory Pipeline Milestones Planned for Combined Company Over the Next 12-18 Months– Companies to Host Joint Conference Call on Tuesday, June 2, 2020 at 8:30 am EDTBERKELEY, Calif., VANCOUVER, British Columbia and SEATTLE, Wash., June 02, 2020 (GLOBE NEWSWIRE) — Aduro Biotech, Inc. (“Aduro”) (NASDAQ: ADRO) and Chinook Therapeutics, Inc. (“Chinook”), a privately held clinical-stage biotechnology company focused on the discovery, development and commercialization...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.